These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3569380)

  • 1. Pharmacokinetic profile of fosfomycin trometamol (Monuril).
    Segre G; Bianchi E; Cataldi A; Zannini G
    Eur Urol; 1987; 13 Suppl 1():56-63. PubMed ID: 3569380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction.
    Bergogne-Bérézin E; Muller-Serieys C; Joly-Guillou ML; Dronne N
    Eur Urol; 1987; 13 Suppl 1():64-8. PubMed ID: 3569381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
    Wenzler E; Ellis-Grosse EJ; Rodvold KA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of fosfomycin trometamol.
    Bergan T; Thorsteinsson SB; Albini E
    Chemotherapy; 1993; 39(5):297-301. PubMed ID: 8370321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fosfomycin-trometamol (monuril): pharmacokinetics and food-drug interactions].
    Muller-Serieys C; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):753-6. PubMed ID: 3309810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity.
    Bergan T
    Infection; 1990; 18 Suppl 2():S65-9. PubMed ID: 2286464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosfomycin kinetics after intravenous and oral administration to human volunteers.
    Goto M; Sugiyama M; Nakajima S; Yamashina H
    Antimicrob Agents Chemother; 1981 Sep; 20(3):393-7. PubMed ID: 7305325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal.
    Borgia M; Longo A; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):411-7. PubMed ID: 2793277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of fosfomycin and its bioavailability.
    Cadórniga R; Diaz Fierros M; Olay T
    Chemotherapy; 1977; 23 Suppl 1():159-74. PubMed ID: 832511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
    Bergan T
    Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
    Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
    Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trometamol salt of fosfomycin (Monuril). Preliminary pharmacokinetic and clinical experience in the treatment of urinary tract infections in children.
    Careddu P; Borzani M; Varotto F; Garlaschi L; Fontana P
    Eur Urol; 1987; 13 Suppl 1():114-8. PubMed ID: 3552695
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses.
    Zozaya DH; Gutiérrez OL; Ocampo CL; Sumano LH
    J Vet Pharmacol Ther; 2008 Aug; 31(4):321-7. PubMed ID: 18638292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies.
    Kuemmerle HP; Murakawa T; Sakamoto H; Sato N; Konishi T; De Santis F
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):521-8. PubMed ID: 4066076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients.
    Janknegt R; Hooymans PM; Fabius GT; Nohlmans-Paulssen MK; Machielsen C; Boogaard-van den Born J; Rang J; Smits CA; Willems-Thissen ME; Krommenhoek A
    Pharm World Sci; 1994 Jun; 16(3):149-53. PubMed ID: 7920366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of fosmidomycin, a new phosphonic acid antibiotic.
    Kuemmerle HP; Murakawa T; De Santis F
    Chemioterapia; 1987 Apr; 6(2):113-9. PubMed ID: 3594633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosfomycin: Absorption and excretion.
    Shimizu K
    Chemotherapy; 1977; 23 Suppl 1():153-8. PubMed ID: 12926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies.
    Kuemmerle HP; Murakawa T; Soneoka K; Konishi T
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):515-20. PubMed ID: 4066075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
    Dubini F; Riviera L
    Chemioterapia; 1988 Feb; 7(1):15-9. PubMed ID: 3259909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers.
    Wijma RA; Koch BCP; van Gelder T; Mouton JW
    Clin Microbiol Infect; 2018 May; 24(5):528-532. PubMed ID: 28867662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.